Showing results (1671-1680 of 2,364) with videos related to

Sort By:
Pageof 237
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 5, 2023
Coils embolization use for coronary procedures: Basics, indications, and techniquesShu Xian Loh, Emmanuelle Brilakis, Gabriele Gasparini, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 6, 2010
Vascular responses to the multiple overlapped paclitaxel-eluting stents for the treatment of bare-metal in-stent restenotic lesions: angiographic and intravascular ultrasound analysis from the TAXUS-V ISR trialTomomi Koizumi, Peter J Fitzgerald, Yasuhiro Honda, et al.
Journal of the American College of Cardiology|July 24, 2010
When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trialsBruce R Brodie, Bernard J Gersh, Thomas Stuckey, et al.
The American Journal of Cardiology|February 18, 2019
Relationship Between Optimism and Outcomes in Patients With Chronic Angina PectorisAlexander C Fanaroff, Kristi Prather, Amanda Brucker, et al.
Journal of Leukocyte Biology|December 7, 2005
Identification of a phenotypically and functionally distinct population of long-lived neutrophils in a model of reverse endothelial migrationChristopher D Buckley, Ewan A Ross, Helen M McGettrick, et al.
The American Journal of Cardiology|December 22, 1999
In-hospital and long-term results of stent deployment compared with balloon angioplasty for treatment of narrowing at the saphenous vein graft distal anastomosis siteL Gruberg, M K Hong, R Mehran, et al.
The American Journal of Cardiology|November 15, 2000
Optimally deployed stents in the treatment of restenotic versus de novo lesionsL Gruberg, M K Hong, G S Mintz, et al.
The New England Journal of Medicine|June 23, 2001
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularizationE J Topol, D J Moliterno, H C Herrmann, et al.
JACC. Cardiovascular Interventions|April 22, 2022
Dual Antiplatelet Therapy Discontinuation, Platelet Reactivity, and Adverse Outcomes After Successful Percutaneous Coronary InterventionBjörn Redfors, Ajay J Kirtane, Mengdan Liu, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 17, 2009
Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trialAlexandra J Lansky, Vivian G Ng, Halil Mutlu, et al.
Pageof 237